Norfloxacin Zn(II)-based complexes: Acid base ionization constant determination, DNA and albumin binding properties and the biological effect against Trypanosoma cruzi

BioMetals

Volumn 26, Issue 5, 2013, Pages 813-825

  Gouvea, Ligiane R ^a   Martins, Darliane A ^a   Da Gama Jean Batista, Denise ^b   De Nazaré C Soeiro, Maria ^b   Louro, Sonia R W ^c   Barbeira, Paulo J S ^a   Teixeira, Letícia R ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acid ionization constant; Anti T. cruzi activity; Interaction with bovine serum albumin; Interaction with DNA; Norfloxacin; Zn(II) complexes

Indexed keywords

ANTIPROTOZOAL AGENT; BOVINE SERUM ALBUMIN; CALF THYMUS DNA; DNA; NORFLOXACIN; ORGANOMETALLIC COMPOUND; ZINC;

ANIMAL; BINDING SITE; BOVINAE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SENSITIVITY; FLUORESCENCE; PH; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TRYPANOSOMA CRUZI;

ANIMALS; ANTIPROTOZOAL AGENTS; BINDING SITES; CATTLE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE; HYDROGEN-ION CONCENTRATION; NORFLOXACIN; ORGANOMETALLIC COMPOUNDS; PARASITIC SENSITIVITY TESTS; SERUM ALBUMIN, BOVINE; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOSOMA CRUZI; ZINC;

EID: 84885473670     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-013-9661-z     Document Type: Article

References (40)

1. Appelbaum PC, Hunter PA (2000) The fluoroquinolones: past, present and future perspectives. Int J Antimicrob Agents 16:5-15
2. Arounaguiri S, Easwaramoorthy D, Ashokkumar A, Dattagupta A, Maiya BG (2000) Cobalt(III), nickel(II) and ruthenium(II) complexes of 1,10-phenanthroline family of ligands: DNA binding and photocleavage studies. Proc Indian Acad Sci 112:1-17
3. Batista DGJ da, Silva PB da, Stivanin L, Lachter DR, Silva RS, Felcman J, Louro SRW, Teixeira LR, Soeiro M de NC (2011) Co(II), Mn(II) and Cu(II) complexes of fluoroquinolones: synthesis, spectroscopical studies and biological evaluation against Trypanosoma cruzi. Polyhedron 30:1718-1725
4. Batista DGJ, Pacheco MGO, Kumar A, Branowska D, Ismail MA, Hu L, Boykin DW, Soeiro MNC (2009) Biological, ultrastructural effect and subcellular localization of aromatic diamidines in Trypanosoma cruzi. Parasitology 137:251-259
5. Batista DGJ, Silva PB, Garcia LS, Lachter DR, Silva RS, Felcman J, Louro SRW, Teixeira LR, Soeiro MNC (2011) Co(II), Mn(II) and Cu(II) complexes of fluoroquinolones: synthesis, spectroscopical studies and biological evaluation against Trypanosoma cruzi. Polyhedron 30:1718-1725
6. Coura JR, Dias JC (2009) Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery. Mem Inst Oswaldo Cruz 104:31-40
7. Cox PJ, Psomas G, Bolos CA (2009) Characterization and DNA-interaction studies of 1,1-dicyano-2,2-ethylene dithiolate Ni(II) mixed-ligand complexes with 2-amino-5-methyl thiazole, 2-amino-2-thiazoline and imidazole. Crystal structure of [Ni(i-MNT)(2a-5mt)(2)]. Bioorg Med Chem 17:6054-6062
8. Daliry A, da Silva PB, da Silva CF, Batista MM, de Castro SL, Tidwell RR, Soeiro MNC (2009) In vitro analyses of the effect of aromatic diamidines upon Trypanosoma cruzi. J Antimicrob Chemother 64:747-750
9. Deacon GB, Phillips RJ (1980) Relationships between the carbon-oxygen stretching frequencies of carboxylato complexes and the type of carboxylate coordination. Coord Chem Rev 33:227-250
10. Dhar S, Nethaji M, Chakravarty AR (2005) Effect of charge transfer bands on the photo-induced DNA cleavage activity of [1-(2-thiazolylazo)-2-naphtholato] copper(II) complexes. J Inorg Biochem 99:805-812
11. Dias JC (2007) Southern cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation and perspectives. Mem Inst Oswaldo Cruz 102:11-18
12. Dorofeev VL (2004) Infrared spectra and the structure of drugs of the fluoroquinolone group. Pharm Chem J 38:693-697
13. 2+ complexes with ligands of biological interest: a DFT/CDM study. J Am Chem Soc 122:11146-11153
14. Emami S, Shafiee A, Foroumadi A (2005) Quinolones: recent structural and clinical developments. Iran J Pharm Res 3:123-136
15. Gao F, Yang P, Xie J, Wang H (1995) Synthesis, characterization and antibacterial activity of novel Fe(III), Co(II), and Zn(II) complexes with norfloxacin. J Inorg Biochem 60:61-67
16. Geary WJ (1971) The use of conductivity measurements in organic solvents for the characterization of coordination compounds. Coord Chem Rev 7:81-122
17. Hooper DC (1999) Mechanisms of fluoroquinolone resistance. Drug Resist Updates 2:38-55
18. Hulme EC, Trevethick MA (2010) Ligand binding assays at equilibrium: validation and interpretation. Br J Pharmacol 161:1219-1237
19. Kamat BP (2005) Study of the interaction between fluoroquinolones and bovine serum albumin. J Pharm Biomed Anal 39:1046-1050
20. Lakowicz JR (2004) Principles of fluorescence spectroscopy, 2nd edn. Springer, New York
21. Lakowicz JR, Weber G (1973) Quenching of fluorescence by oxygen: probe for structural fluctuations in macromolecules. Biochemistry 12:4161-4170
22. Luiz FCL, Garcia LS, Goes Filho LS, Teixeira LR, Louro SRW (2011) Fluorescence studies of gold(III)-norfloxacin complexes in aqueous solutions. J Fluoresc 21:1933-1940
23. Marmur J (1961) A procedure for the isolation of deoxyribonucleic acid from microorganisms. J Mol Biol 3:208-218
24. Martins DA, Gouvea LR, Gama JBD da, Silva PB da, Louro SR, Soeiro M de NC, Teixeira LR (2012) Copper(II)-fluoroquinolone complexes with anti-Trypanosoma cruzi activity and DNA binding ability. BioMetals 25:951-960
25. Meirelles MN, de Araujo-Jorge TC, de Souza W (1982) Interaction of Trypanosoma cruzi with macrophages in vitro: dissociation of the attachment and internalization phases by low temperature and cytochalasin B. Z Parasitenkd 68:7-14
26. Park H-R, Kim TH, Bar K-M (2002) Physicochemical properties of quinolone antibiotics in various environments. Eur J Med Chem 37:443-460
27. Patrick GL (1995) An introduction to medicinal chemistry. Oxford University Press, New York
28. Perrin DD, Dempsey B (1974) Buffers for pH and metal ion control. Chapman and Hall, New York
29. Pyle AM, Rehmann JP, Meshoyrer R, Kumar CV, Turro NJ, Barton JK (1989) Mixed-ligand complexes of ruthenium(II): factors governing binding to DNA. J Am Chem Soc 111:3051-3058
30. Refat MS (2007) Synthesis and characterization of norfloxacin-transition metal complexes (group 11, IB): spectroscopic, thermal, kinetic measurements and biological activity. Spectrochim Acta A 68:1393-1405
31. Refat MS, Mohamed GG, de Farias RF, Powell AK, El-Garib MS, El-Korashy SA, Hussien MA (2010) Spectroscopic, thermal and kinetic studies of coordination compounds of Zn(II), Cd(II) and Hg(II) with norfloxacin. J Therm Anal Calorim 102:225-232
32. Sadeek SA (2005) Synthesis, thermogravimetric analysis, infrared, electronic and mass spectra of Mn(II), Co(II) and Fe(III) norfloxacin complexes. J Mol Struct 753:1-12
33. Saha DK (2004) A novel mixed-ligand antimycobacterial dimeric copper complex of ciprofloxacin and phenanthroline. Bioorg Med Chem Lett 14:3027-3032
34. Shaikh AR, Giridhar R, Yadav MR (2007) Bismuth-norfloxacin complex: synthesis, physicochemical and antimicrobial evaluation. Int J Pharm 332:24-30
35. Silva CF, Batista DG, Oliveira GM, Souza EM, Hamer ER, da Silva PB, Daliry A, Araujo JS, Brito C, Rodrigues ACM, Liu Z, Farahat AA, Kumar A, Boykin D, Blader I, Soeiro MNC (2012) In vitro and in vivo investigation of the efficacy of arylimidamide DB1831 and its mesylated salt form-DB1965-against Trypanosoma cruzi infection. PLoS One 7:30356
36. Skyrianou KC, Efthimiadou EK, Psycharis V, Terzis A, Kessissoglou DP, Psomas G (2009) Nickel-quinolones interaction. Part 1-nickel(II) complexes with the antibacterial drug sparfloxacin: structure and biological properties. J Inorg Biochem 103:1617-1625
37. Skyrianou KC, Perdih F, Turel I, Kessissoglou DP, Psomas G (2010) Nickel-quinolones interaction. Part 3-nickel(II) complexes of the antibacterial drug flumequine. J Inorg Biochem 104:740-749
38. Soeiro MNC de, Castro SL de (2011) Screening of potential anti-Trypanosoma cruzi candidates: in vitro and in vivo studies. Open Med Chem J 5:21-30
39. Wang Y, Zhang H, Zhang G, Tao W, Tang S (2007) Interaction of the flavonoid hesperidin with bovine serum albumin: a fluorescence quenching study. J Lumin 126:211-218
40. 2O. Polyhedron 25:2985-2992